1. |
涂小煌, 张再重, 陈少全, 等. 全直肠系膜切除术安全远切端距离的临床研究 [J]. 中国普通外科杂志, 2009; 18(11): 11751179.
|
2. |
涂小煌, 张再重, 宋京翔, 等. 大口径肛管预防直肠癌术后吻合口漏的对比研究 [J]. 中国普外基础与临床杂志, 2009; 16(10): 830833.
|
3. |
范恩学, 房学东, 孙海侠, 等. 直肠癌TME与非TME手术的临床分析 [J]. 中国现代普通外科进展, 2009; 12(10): 875878.
|
4. |
刘征云, 田福年. 应用TME技术治疗中低位直肠癌的体会[J]. 中国普外基础与临床杂志, 2008; 15(11): 844845.
|
5. |
den Dulk M, Collette L, van de Velde CJ, et al. Quality of surgery in T34 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Restult from EORTC trial 22921[J]. Eur J Cancer, 2007; 43(12): 18211828.
|
6. |
Ulrich A, Weitz J, Slodczyk M, et al. Neoadjuvant treatment does not influence perioperative outcome in rectal cancer surgery[J]. Int J Radiat Oncol Biol Phys, 2009; 75(1): 129136.
|
7. |
章卫根, 章俊杰, 黄军平. 中低位直肠癌新辅助治疗的远期疗效 [J]. 实用医学杂志, 2009; 25(11): 18061807.
|
8. |
Twu CM, Wang HM, Chen JB, et al. Neoadjuvant concurrent chemoradiotherapy in treating locally advanced rectal cancer[J]. J Chin Med Assoc, 2009; 72(4): 179182.
|
9. |
唐宗江, 郭云, 唐卫中. 术前放化疗对低位直肠癌患者细胞免疫功能及保肛的影响 [J]. 结直肠肛门外科, 2007; 13(3): 150152.
|
10. |
郁宝铭, 吴唯勤. 新辅助化放疗与TME联合治疗局部进展期低位直肠癌 [J]. 中国实用外科杂志, 2005; 25(5): 270272.
|
11. |
Beddy D, Hyland JM, Winter DC, et al. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy [J]. Ann Surg Oncol, 2008; 15(12): 34713477.
|
12. |
Caricato M, Ausania F, De Dominicis E, et al. Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer[J]. Eur J Surg Oncol, 2007; 33(6): 724728.
|
13. |
曾智帆, 丁培荣, 潘志忠, 等. 直肠癌新辅助治疗后淋巴结转移相关因素分析 [J]. 癌症, 2009; 28(9): 923927.
|
14. |
Ciccocioppo A, Stephens JH, Hewett PJ, et al. Complete pathologic response after preoperative rectal cancer chemoradiotherapy[J]. ANZ J Surg, 2009; 79(6): 481484.
|
15. |
Castaldo ET, Parikh AA, Pinson CW, et al. Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer[J]. Arch Surg, 2009; 144(2): 129135.
|
16. |
郁宝铭, 张敏, 吴唯勤. 肿瘤降期在低位直肠癌新辅助治疗中的意义 [J]. 世界华人消化杂志, 2007; 15(32): 34463450.
|
17. |
Roh MS, Colangelo LH, O’Connell MJ, et al. Preoperative multimodality therapy improves diseasefree survival in patients with carcinoma of the rectum: NSABP R03[J]. J Clin Oncol, 2009; 27(31): 51245130.
|
18. |
Dhadda AS, Zaitoun AM, Bessell EM. Regression of rectal cancer with radiotherapy with or without concurrent capecitabine—optimising the timing of surgical resection[J]. Clin Oncol (R Coll Radiol), 2009; 21(1): 2331.
|
19. |
HabrGama A, Perez RO, Sabbaga J, et al. Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period[J]. Dis Colon Rectum, 2009; 52(12): 19271934.
|
20. |
Sato T, Kokuba Y, Koizumi W, et al. Phase Ⅰ trial of neoadjuvant preoperative chemotherapy with S1 and irinotecan plus radiation in patients with locally advanced rectal cancer[J]. Int J Radiat Oncol Biol Phys, 2007; 69(5): 14421447.
|
21. |
Kim NK, Kim YW, Min BS, et al. Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer [J]. World J Surg, 2009; 33(8): 17411749.
|
22. |
顾晋, 詹天成, 姚云峰. 结直肠癌的新辅助化疗 [J]. 中国普外基础与临床杂志, 2007; 14(6): 628629.
|
23. |
HoPunCheung A, Assenat E, Thezenas S, et al. Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer[J]. Int J Radiat Oncol Biol Phys, 2007; 68(4): 10941101.
|
24. |
Lin LC, Lee HH, Hwang WS, et al. p53 and p27 as predictors of clinical outcome for rectalcancer patients receiving neoadjuvant therapy[J]. Surg Oncol, 2006; 15(4): 211216.
|
25. |
Yasuda H, Tanaka K, Saigusa S, et al. Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer[J]. Oncol Rep, 2009; 22(4): 709717.
|
26. |
Perez RO, So Julio GP, HabrGama A, et al. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer[J]. Dis Colon Rectum, 2009; 52(6): 11371143.
|
27. |
Moreno García V, Cejas P, Blanco Codesido M, et al. Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy[J]. Int J Colorectal Dis, 2009; 24(7): 741748.
|
28. |
Baik SH, Kim NK, Lee KY, et al. Analysis of anal sphincter preservation rate according to tumor level and neoadjuvant chemoradiotherapy inrectal cancer patients[J]. J Gastrointest Surg, 2008; 12(1): 176182.
|
29. |
Pucciarelli S, Toppan P, Friso ML, et al. Complete pathologic response follow preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome[J]. Dis Colon Rectum, 2004; 47(11): 17981807.
|